Controversies in the management of febrile neutropenic cancer patients.
D000380:Agranulocytosis / Q000150:complications*; D000465:Algorithms; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use; D005334:Fever / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D017053:Infection Control; D007239:Infections / Q000188:drug therapy* / Q000209:etiology; D007769:Lactams; D009369:Neoplasms / Q000150:complications*; D009503:Neutropenia / Q000150:complications* / Q000628:therapy; D011014:Pneumonia / Q000188:drug therapy / Q000209:etiology; D011804:Quinolines / Q000627:therapeutic use; D014640:Vancomycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000935:Antifungal Agents; D007769:Lactams; D011804:Quinolines; D014640:Vancomycin